IHL ASX Chart
Snapshot
Incannex Healthcare Limited (IHL) is a clinical stage pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, and pain, among other indications.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2025 YTD | |
1 Year | |
vs Sector (1yr) | -78.25% |
vs ASX 200 (1yr) | -84.98% |
Key Fundamentals
Shares Issued | |
Sector | Healthcare |
Similar Companies | - |
EPS | $0.00 |
DPS | $0.00 |
Book Value Per Share | $0.00 |
Broker Consensus
IHL is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.
Announcements
Corporate Overview
Corporate Details
Head Office | |
Website | - |
Registry | Automic Group |
Auditor | PKF BRISBANE AUDIT |
Date Listed | 23 May 2007 |
Upcoming Calendar (Forecasted)
No calendar entries available.
Former Company Names
- Impression Healthcare Limited (IHL), 03/07/2020
- Mount Magnet South Limited (MUM), 28/10/2016
- Mount Magnet South NL (MUM), 02/12/2015
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
IHL directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of IHL directors.
Shareholder Info
Substantial Shareholders
No Substantial Shareholders for IHL in our database.
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.06 | 31 October |
2023 | $0.10 | 30 June |
2022 | $0.21 | 30 June |
2021 | $0.25 | 30 June |
2020 | $0.046 | 30 June |
2019 | $0.04 | 28 June |
2018 | $0.023 | 29 June |
2017 | $0.031 | 30 June |
2016 | $0.004 | 30 June |
2015 | $0.004 | 30 June |
2014 | $0.003 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.